Sign Up for Updates

For important news and updates about ONSOLIS™
When the full ONSOLIS website for patients and healthcare professionals goes online
When the Risk Evaluation and Mitigation Strategy (REMS) registration for ONSOLIS is available to healthcare providers

We will keep our communications brief and to the point, and you may opt out at any time.

I am a Healthcare Professional.

Professional Designation *

Specialty *

Email *

Email Confirmation *

First Name *

Last Name *

Address 1

Address 2

City

State

Zip *

I agree to the Privacy Policy.

Meda Pharmaceuticals respects your privacy – and is committed to keeping your personal information private. In order to send you additional information we will need your name, mailing address and email address. By providing this information you agree that Meda and its trusted partners may use this information to:

Provide me with information regarding ONSOLIS and related treatment options, and other Meda Pharmaceuticals Inc. products and services.
Develop products and services concerning related treatment options, which may include market research.

View Privacy Statement

Onsolis - fentanyl buccal soluble firm - Adheres. Dissolves. Delivers

Sign Up for Updates